Sequenom

Bringing the power of science to healthcare. Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier lives through the development of innovative products and services. We serve patients and physicians by providing early patient management information. What makes this vision a reality? Our deep commitment to "Quality of Science." For us, only the highest quality is acceptable. We accept nothing less in the science that supports every product and service we offer. From development to commercialization of innovative tests, "Quality of Science" is the common element in everything we do.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1994
Size (employees)
434 (est)
Sequenom was founded in 1994 and is headquartered in San Diego, US

Sequenom Office Locations

Sequenom has offices in San Diego, Salt Lake City, New York, Philadelphia and in 17 other locations
San Diego, US (HQ)
3595 John Hopkins Ct

Sequenom Data and Metrics

Sequenom Financial Metrics

Sequenom's revenue was reported to be $128.3 m in FY, 2015 which is a 15% decrease from the previous period.
Numbers are in $, USD

Revenue (FY, 2015)

128.3 m

Revenue growth (FY, 2014 - FY, 2015), %

(15%)

Gross profit (FY, 2015)

61.3 m

Gross profit margin (FY, 2015), %

48%

Net income (FY, 2015)

(16.3 m)

EBIT (FY, 2015)

(7.9 m)

Market capitalization (01-Sep-2016)

286.2 m

Closing share price (01-Sep-2016)

2.4

Cash (31-Dec-2015)

50.3 m
Sequenom's current market capitalization is $286.2 m.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015

Revenue

162.4 m151.6 m128.3 m

Revenue growth, %

(7%)(15%)

Cost of goods sold

102.7 m83.5 m67 m

Gross profit

59.7 m68.1 m61.3 m

Gross profit Margin, %

37%45%48%

R&D expense

25 m

General and administrative expense

46.9 m

Operating expense total

158.1 m104.6 m157.9 m

EBIT

(98.4 m)(13.7 m)(7.9 m)

EBIT margin, %

(61%)(9%)(6%)

Interest expense

8.4 m8.2 m8.1 m

Interest income

55 k71 k

Pre tax profit

(107.1 m)(22 m)(16.1 m)

Income tax expense

(301 k)(7.7 m)(244 k)

Net Income

(107.4 m)1 m(16.3 m)
Numbers are in $, USDFY, 2013FY, 2014FY, 2015

Cash

61.6 m63.3 m50.3 m

Accounts Receivable

10.2 m9.1 m6.4 m

Inventories

17 m6.5 m2.4 m

Current Assets

101.5 m121.7 m89 m

Goodwill

10 m10 m10 m

Total Assets

144.7 m161.1 m118.8 m

Accounts Payable

10 m6.1 m5.2 m

Current Liabilities

49.6 m56 m21.5 m

Additional Paid-in Capital

967 m981.9 m991 m

Retained Earnings

(1 b)(1 b)(1 b)

Total Equity

(31.2 m)(38.4 m)

Financial Leverage

-5.2 x-3.1 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015

Net Income

(107.4 m)1 m(16.3 m)

Depreciation and Amortization

15.1 m12.2 m

Accounts Receivable

(2.3 m)(6.6 m)

Inventories

(6.2 m)5.1 m

Accounts Payable

(90 k)(5.7 m)

Cash From Operating Activities

(85.6 m)(28.1 m)(13 m)

Cash From Investing Activities

29.4 m32.9 m

Cash From Financing Activities

(6.1 m)(5.7 m)

Interest Paid

7.4 m7.1 m
Numbers are in $, USDY, 2015

Revenue/Employee

318.6 k

Financial Leverage

-3.1 x

Sequenom Online and Social Media Presence

Sequenom News and Updates

Sequenom Company Life and Culture

You may also be interested in